WHAT IS DRIVING SCIENTISTS LIKE OURSELVES?

On the 31st of January we had our first 3TR – ABC Research Meeting! More than 50 3TR members participated with lots of enthusiasm, providing insightful comments and food for our thoughts! We had a remarkable presentation of Prof. Dr. Peter J. Sterk on “How to develop research questions in an international consortium”, followed by the presentation of the actual research questions and substudies within the 3TR – ABC project. Moreover,…

The AMC is on board the 3TR-ABC!

The second center of the 3TR–ABC study – the Amsterdam Medical University Center – is happy to announce that it is now actively recruiting severe asthma patients commenced on biologics. The first baseline visit went perfectly, and we are keeping a strong and continuous collaboration with the team in Denmark. We are proud and glad to be part of this amazing innovative project! Looking forward to seeing our first results soon!…

CROSS-SITE VISIT

The first cross-site visit has just been held. The team from Amsterdam UMC visited Bispebjerg Hospital the 15th-16th september to get an insight in how the danish team runs the study. Soon as the study protocol has been approved by the ethics commitee in the Netherlands, the team in Amsterdam will be ready to recruite participants!!!

FIRST DATA FROM THE 3TR-ABC STUDY PRESENTED AT THE ERS CONGRESS 2022

We are thrilled to annouce that the first data results from the 3TR-ABC study have been presented at the European Respiratory Society Congress 2022 in Barcelona. C. Bernhoff and colleagues have found that participants with severe asthma show signs of cognitive impairment – a found that is well in line with patient reports of decreased concentration and memory. Sofar the results are based on a limited number of patients but as…

First bronchoscopy in 3TR-ABC

Dear AllToday the first 3TR-ABC patient underwent bronchoscopy – The procedure went well, and the patient will now recieve her first dose of medication.  Consultant Alexis Pulga performed the procedure, using the novel mucosa cryobiopsy method developed at Bispebjerg Hospital, together with post doc, Ph.D. MD Morten Hvidtfeldt We are very excited to have made such a great start to the 3TR-ABC study! –  5 patients enrolled over the first month (4 on Dupixent,…

Bispebjerg Hospital has begun the 3TR-ABC study!

Dear All We at Bisbjerg Hospital in Denmark are so HAPPY to inform that the first study participant in the 3TR-ABC study has been recruited. The baseline visit has already been performed and we are pleased to tell that it went fine. All the hard work and preparation from 3TR and colleagues have really payed off ? We are now looking forward to the second and third participant who are already…

Bispebjerg Hospital soon to begin the 3TR-ABC study!

We are so happy to announce that the Respiratory Research Unit at Bispebjerg Hospital, Copenhagen, Denmark, will be the first site to recruit patients to the 3TR-ABC study. The recruitment will begin in January and the site will recruit patients with severe asthma from the hospital’s out-patient clinic. The clinic will keep on standing for the medical treatment of the patients though, all tests and investigations will happen as part of…

3TR-ABC is ready to start!

We are pleased to announce that recruitment into the 3TR-ABC study will soon commence! The first site to start is Bispebjerg Hospital in Copenhagen, Denmark, where all approvals from the authorities now are in place. From November 2021, all patients commencing on a biologic at Bispebjerg Hospital will be offered to participate in 3TR-ABC – thereby enabling us to learn more about severe asthma, and how we may improve existing treatments…

IBD Biomarker Regulatory Science Webinar on 10 March 2021: 3TR Partners Host Joint Workshop with Critical Path Institute

The 3TR teams for Inflammatory Bowel Disease (IBD) and Engagement with Regulators have joined forces with the Critical Path Institute to host an IBD Biomarker Regulatory Science Webinar on Wednesday 10 March 2021 from 10 AM to 1 PM (ET) / 4 to 7 PM (CET). Bringing together key stakeholders from the IBD medical community, representatives of public research institutes, industry members and patient advocates, the three-hour LIVE session aims to understand…